CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Adjustment	Adjustment Additional Paid-in Capital	Adjustment Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 243,934	$ 70	$ (3)	$ 635,672	$ (391,885)	$ 80
Beginning balance (in shares) at Dec. 31, 2020		70,264,265	(2,709,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	2,617			2,617
Common stock issued upon exercise of stock options (in shares)		209,185
Common stock issued upon vesting of restricted stock units (“RSUs”)	0	$ 1		(1)
Common stock issued upon vesting of restricted stock units (in shares)		454,508
Stock-based compensation	9,225			9,225
Cash awards settled in shares of the Company’s common stock	25,925			25,925
Cash awards settled in shares of the company's common stock (in shares)		400,700
Common stock issued under Employee Stock Purchase Plan	1,257			1,257
Common stock issued under Employee Stock Purchase Plan (in shares)		22,544
Net loss	(21,195)				(21,195)
Other comprehensive loss	(1,746)					(1,746)
Ending balance at Mar. 31, 2021	260,017	$ 71	$ (3)	674,695	(413,080)	(1,666)
Ending balance (in shares) at Mar. 31, 2021		71,351,202	(2,709,830)
Beginning balance at Dec. 31, 2020	243,934	$ 70	$ (3)	635,672	(391,885)	80
Beginning balance (in shares) at Dec. 31, 2020		70,264,265	(2,709,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(75,121)
Ending balance at Sep. 30, 2021	262,109	$ 73	$ (3)	733,202	(467,006)	(4,157)
Ending balance (in shares) at Sep. 30, 2021		72,723,049	(2,709,830)
Beginning balance at Mar. 31, 2021	260,017	$ 71	$ (3)	674,695	(413,080)	(1,666)
Beginning balance (in shares) at Mar. 31, 2021		71,351,202	(2,709,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	3,999			3,999
Common stock issued upon exercise of stock options (in shares)		252,155
Common stock issued upon vesting of restricted stock units (“RSUs”)	0	$ 1		(1)
Common stock issued upon vesting of restricted stock units (in shares)		252,218
Stock-based compensation	9,524			9,524
Cash awards settled in shares of the Company’s common stock	7,578			7,578
Cash awards settled in shares of the company's common stock (in shares)		137,300
Common stock issued under Employee Stock Purchase Plan	1,128			1,128
Common stock issued under Employee Stock Purchase Plan (in shares)		24,270
Net loss	(21,119)				(21,119)
Other comprehensive loss	565					565
Ending balance at Jun. 30, 2021	261,692	$ 72	$ (3)	696,923	(434,199)	(1,101)
Ending balance (in shares) at Jun. 30, 2021		72,017,145	(2,709,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	3,036			3,036
Common stock issued upon exercise of stock options (in shares)		191,693
Common stock issued upon vesting of restricted stock units (“RSUs”)	0
Common stock issued upon vesting of restricted stock units (in shares)		142,867
Stock-based compensation	12,148			12,148
Common stock issued under Employee Stock Purchase Plan	1,083			1,083
Common stock issued under Employee Stock Purchase Plan (in shares)		19,882
Net loss	(32,807)
Other comprehensive loss	(3,056)					(3,056)
Ending balance at Sep. 30, 2021	262,109	$ 73	$ (3)	733,202	(467,006)	(4,157)
Ending balance (in shares) at Sep. 30, 2021		72,723,049	(2,709,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with acquisitions	20,013	$ 1		20,012
Issuance of common stock in connection with acquisitions (in shares)		351,462
Ending balance at Dec. 31, 2021	349,437	$ 75	$ (3)	871,788	(516,859)	(5,564)
Ending balance (Accounting Standards Update 2020-06) at Dec. 31, 2021							$ (159,407)	$ (209,651)	$ 50,244
Ending balance (in shares) at Dec. 31, 2021		74,980,546	(2,746,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	506			506
Common stock issued upon exercise of stock options (in shares)		40,483
Common stock issued upon vesting of restricted stock units (“RSUs”)	0
Common stock issued upon vesting of restricted stock units (in shares)		444,043
Stock-based compensation	20,522			20,522
Cash awards settled in shares of the Company’s common stock	17,299	$ 1		17,298
Cash awards settled in shares of the company's common stock (in shares)		735,519
Common stock issued under Employee Stock Purchase Plan	1,415			1,415
Common stock issued under Employee Stock Purchase Plan (in shares)		82,100
Issuance of common stock in connection with acquisitions	17,637	$ 1		17,636
Issuance of common stock in connection with acquisitions (in shares)		779,946
Net loss	(65,364)				(65,364)
Other comprehensive loss	(1,699)					(1,699)
Ending balance at Mar. 31, 2022	180,346	$ 77	$ (3)	719,514	(531,979)	(7,263)
Ending balance (in shares) at Mar. 31, 2022		77,062,637	(2,746,243)
Beginning balance at Dec. 31, 2021	$ 349,437	$ 75	$ (3)	871,788	(516,859)	(5,564)
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021							$ (159,407)	(209,651)	50,244
Beginning balance (in shares) at Dec. 31, 2021		74,980,546	(2,746,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)	200,000
Net loss	$ (184,023)
Ending balance at Sep. 30, 2022	89,511	$ 78	$ (3)	757,162	(650,638)	(17,088)
Ending balance (Accounting Standards Update 2020-06) at Sep. 30, 2022								(209,700)	50,200
Ending balance (in shares) at Sep. 30, 2022		77,934,440	(2,746,243)
Beginning balance at Mar. 31, 2022	180,346	$ 77	$ (3)	719,514	(531,979)	(7,263)
Beginning balance (in shares) at Mar. 31, 2022		77,062,637	(2,746,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	389			389
Common stock issued upon exercise of stock options (in shares)		25,295
Common stock issued upon vesting of restricted stock units (“RSUs”)	1	$ 1		0
Common stock issued upon vesting of restricted stock units (in shares)		372,500
Stock-based compensation	18,826			18,826
Common stock issued under Employee Stock Purchase Plan	1,403			1,403
Common stock issued under Employee Stock Purchase Plan (in shares)		99,495
Net loss	(75,411)				(75,411)
Other comprehensive loss	(4,799)					(4,799)
Ending balance at Jun. 30, 2022	120,755	$ 78	$ (3)	740,132	(607,390)	(12,062)
Ending balance (in shares) at Jun. 30, 2022		77,559,927	(2,746,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options	343			343
Common stock issued upon exercise of stock options (in shares)		134,423
Common stock issued upon vesting of restricted stock units (“RSUs”)	0
Common stock issued upon vesting of restricted stock units (in shares)		161,272
Stock-based compensation	15,843			15,843
Common stock issued under Employee Stock Purchase Plan	844			844
Common stock issued under Employee Stock Purchase Plan (in shares)		78,818
Net loss	(43,248)				(43,248)
Other comprehensive loss	(5,026)					(5,026)
Ending balance at Sep. 30, 2022	$ 89,511	$ 78	$ (3)	$ 757,162	$ (650,638)	$ (17,088)
Ending balance (Accounting Standards Update 2020-06) at Sep. 30, 2022								$ (209,700)	$ 50,200
Ending balance (in shares) at Sep. 30, 2022		77,934,440	(2,746,243)